Evidence mapPaperPMID 40529509Full record

SynthesisCardiovascular therapeutics2025

A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases.

Wanying Li, Ding Wang, Caiyue Lin, Tongze Cai, Mei Zhao, Liuguan Liang, Xingxing Zhao, Xin He, Xiaoyue Liang, Jinghui Zheng

Erratum issued Registry-linked trialAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cardiovascular therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07668791 (Efficacy Study of the Supplementation of a Food Supplement Consisting of the Combination of an Olive Extract), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07668791 nacompletednot on this mapstarted 2026, after this paper: background citation

Efficacy Study of the Supplementation of a Food Supplement Consisting of the Combination of an Olive Extract (Olea Europea L., Fruit), and Myrtle Extract (Myrtus Communis L. Leaves) for the Improvement of Lipid Metabolism in Subjects Eith Slightly Altered Cholesterolemia Values: Single-center, Controlled, Randomized, Parallel-arm, Double-blind Clinical Study

TypeinterventionalSponsorLabomar SPARan2026 to 2026Enrolled112ConditionsDyslipidaemiasArmsFood supplement (T1675), Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Wanying LiGraduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0001-4280-3827
Ding WangDepartment of Cardiology, The First People's Hospital of Nanning, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0009-8821-2051
Caiyue LinGraduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0006-8654-8289
Tongze CaiDepartment of Oncology, Guangxi International Zhuang Medicine Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0000-8677-6309
Mei ZhaoDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0002-3815-5596
Liuguan LiangGraduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0008-1556-7268
Xingxing ZhaoGraduate School, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0001-2461-9698
Xin HeDepartment of Cardiology, The First People's Hospital of Nanning, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0005-1786-9487
Xiaoyue LiangDepartment of Cardiology, The First People's Hospital of Nanning, Nanning, Guangxi, China.ORCID https://orcid.org/0009-0002-6573-7145
Jinghui ZhengAcademic Affairs Office, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.ORCID https://orcid.org/0000-0001-5076-6432

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DyslipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsAdultAgedFemaleHumansIncidenceMaleMiddle AgedRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTreatment OutcomeHydroxymethylglutaryl-CoA Reductase Inhibitorsadverse reactionscoronary heart diseasehypercholesterolemiamyalgiastatins

Identifiers

PMID40529509
PMCPMC12173554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.